Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
JAhqe00YWRLevBPd